Research points to the prospect of a once-monthly anti-HIV drug Edit

Once-daily anti-HIV treatment was considered a breakthrough, but researchers are now developing an anti-HIV drug that might need to be taken just once a month.

An experimental NNRTI called rilpivirine has been formulated with nanoparticles. Results in animals suggest that once-monthly injections could be enough to treat HIV.

Researchers are trying to find other drugs that could be formulated in a similar way. This could mean that potent, multi-drug anti-HIV treatment could be developed that is injected monthly.

This technology could also be used for HIV prevention to provide long-lasting pre-exposure prophylaxis or a as a microbicide.

Ad blocker interference detected!

Wikia is a free-to-use site that makes money from advertising. We have a modified experience for viewers using ad blockers

Wikia is not accessible if you’ve made further modifications. Remove the custom ad blocker rule(s) and the page will load as expected.